INS and diabetes mellitus: In this context, the LCHP+3 diet could be a low-cost, accessible, non-drug intervention with quick glucose-lowering and fluctuation-suppressing effects for patients, especially those who need to limit insulin secretion (e.g., diabetes and cancer patients) or those who cannot tolerate other drug treatments.